140 results
8-K
EX-99.1
BCDA
BioCardia Inc.
14 May 24
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
4:06pm
, patients with advanced chronic heart failure who received a single endomyocardial dose of autologous CardiAMP cell therapy had a 37% relative risk … Cell Therapy for Patients with Chronic Myocardial Ischemia (BCDA-02)
The CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial is a Phase III
8-K
EX-99.1
BCDA
BioCardia Inc.
1 May 24
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
7:00am
Exhibit 99.1
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
Sunnyvale … in Chronic Myocardial Ischemia Trial.
Study clinical cardiology leadership and members of the Executive Steering Committee, Dr. Carl Pepine, Professor
8-K
BCDA
BioCardia Inc.
1 May 24
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
7:00am
results of the open label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial. The data was presented in a webcast sponsored
8-K
EX-99.1
boekw
27 Mar 24
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
4:07pm
8-K
00m9p
4 Mar 24
Regulation FD Disclosure
8:00am
8-K
EX-99.1
6ysl3c v8i
4 Mar 24
Regulation FD Disclosure
8:00am
8-K
EX-99.1
blgt3lz
8 Feb 24
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
7:03am
8-K
EX-99.1
dqh7 r0960m1av
31 Jan 24
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
7:00am
8-K
EX-99.1
fjtqv
3 Jan 24
Business Development Update for Shareholders
7:00am
8-K
EX-99.1
seqqlt k8r22g
19 Dec 23
Other Events
7:00am
8-K
EX-99.1
6v50o2ofsy
18 Dec 23
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
7:00am
424B5
zlwou060nyazh yf
6 Dec 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
30zcfj3pha
29 Nov 23
Other Events
7:00am
424B5
bpkooi inw
17 Nov 23
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
6qt a3kotyvwhfowiy
14 Nov 23
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
12:00am